Immunoglobulin hypermutation in cultured cells

Immunological Reviews

Volumn 162, Issue , 1998, Pages 77-87

  Green, Nancy S ^a   Lin, Mark M ^a   Scharff, Matthew D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; TRANS ACTING FACTOR;

ANIMAL CELL; CELL CULTURE; CELL LINE; GENE CONSTRUCT; GENE MUTATION; GENETIC ENGINEERING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; TRANSCRIPTION INITIATION;

ANIMALS; ANTIBODY DIVERSITY; CELLS, CULTURED; GENES, IMMUNOGLOBULIN; GENETIC ENGINEERING; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MUTATION; TRANSGENES;

EID: 0031942085     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01431.x     Document Type: Review

References (75)

1. Weill J-C, Reynaud CA. Rearrangment/hypermutation/gene conversion: when, where and why? Immunol Today 1996;17:92-97.
2. Clarke SH, Huppi K, Ruezinsky D, Staudt L, Gerhard W, Weigert M. Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin. J Exp Med 1985;161:687-704.
3. Berek C, Milstein C. Mutation drift and repertoire shift in the maturation of the immune response. Immunol Rev 1987;96:23-41.
4. Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996;381:751-758.
5. French DL, Laskov R, Scharff MD. The role of somatic hypermutation in the generation of antibody diversity. Science 1989;244:1152-1157.
6. Weigert MG, Cesari IM, Yonkovich SJ, Cohn M. Variability in the lambda light chain sequences of mouse antibody. Nature 1970;228:1045-1047.
7. Kabat E, Wu T, Bilofsky H, Reid-Miller M, Perry H, Gottesman K. Sequences of proteins of immunological interest. Bethesda (MD): US Government Printing Office; 1987.
8. Weigert M. The influence of somatic mutation on the immune response. Prog Immunol 1986;6:138-144.
9. Allen D, et al. Timing, genetic requirements and functional consequences of somatic hypermutation during B-cell development. Immunol Rev 1987;96:5-22.
10. Milstein C. Affinity maturation of antibodies. Immunol Today 1991;12:93-94.
11. Rogozin IB, Kolchanov NA. Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis. Biochim Biophys Acta 1992;1171:11-18.
12. Neuberger MS, Milstein C. Somatic hypermutation. Curr Opin Immunol 1995;7:248-254.
13. Smith DS, Creadon G, Jena PK, Portanova JP, Kotzin BL, Wysocki LJ. Di- and trinucleotide target preferences of somatic mutagenesis in normal and autoreactive B cells. J Immunol 1996;156:2642-2652.
14. Wagner SD, Neuberger MS. Somatic hypermutation of immunoglobulin genes. Annu Rev Immunol 1996;14:441-457.
15. Jolly CJ, Wagner SD, Rada C, Klix N, Milstein C, Neuberger MS. The targeting of somatic mutation. Semin Immunol 1996;8:159-168.
16. MacLennan IC. Germinal centers. Annu Rev Immunol 1994;12:117-139.
17. Kelsoe G. The germinal center: a crucible for lymphocyte selection. Semin Immunol 1996;8:179-184.
18. Matsumoto M, et al. Affinity maturation without germinal centres in lymphotoxin-alpha-deficient mice. Nature 1996;382:462-466.
19. Kosco-Vilbois MH, Zentgraf H, Gerdes J, Bonnefoy J-Y. To "B" or not to "B" a germinal center? Immunol Today 1997;18:225-230.
20. Rothenfluh HS, Taylor L, Bothwell AL, Both GW, Steele EJ. Somatic hypermutation in 5′ flanking regions of heavy chain antibody variable regions. Eur J Immunol 1993;23:2152-2159.
21. Weber JS, Berry J, Manser T, Claflin JL. Mutations in Ig V(D)J genes are distributed asymmetrically and independently of the position of V(D)J. J Immunol 1994;153:3594-3602.
22. Lebecque SG, Gearhart PJ. Boundaries of somatic mutation in rearranged immunoglobulin genes: 5′ boundary is near the promoter, and 3′ boundary is approximately 1 kb from V(D)J gene. J Exp Med 1990;172:1717-1727.
23. Rada C, Gonzalez-Fernandez A, Jarvis JM, Milstein C. The 5′ boundary of somatic hypermutation in a Vk gene is in the leader intron. Eur J Immunol 1994;24:1453-1457.
24. Insel RA, Varade WS. Bias in somatic hypermutation of human VH genes. Int Immunol 1994;6:1437-1443.
25. Dorner T, Brezinschek HP, Brezinschek RI, Foster SJ, Domiati-Saad R, Lipsky PE. Analysis of the frequency and pattern of somatic mutations within nonproductively rearranged human variable heavy chain genes. J Immunol 1997;158:2779-2789.
26. O'Brien RL, Brinster RL, Storb U. Somatic hypermutation of an immunoglobulin transgene in kappa transgenic mice. Nature 1987;326:405-409.
27. Storb U, Peters A, Klotz E, Rogerson B, Hackett J Jr. The mechanism of somatic hypermutation studied with transgenic and transfected target genes. Semin Immunol 1996;8:131-140.
28. Betz AG, Rada C, Pannell R, Milstein C, Neuberger MS. Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots. Proc Natl Acad Sci USA 1993;90:2385-2388.
29. Yelamos J, et al. Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. Nature 1995;376:225-229.
30. Tumas-Brundage K, Vora KA, Giusti AM, Manser T. Characterization of the cis-acting elements required for somatic hypermutation of murine antibody V genes using conventional transgenic and transgene homologous recombination approaches. Semin Immunol 1996;8:141-150.
31. Betz AG, Milstein C, Gonzalez-Fernandez A, Pannell R, Larson T, Neuberger MS. Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region. Cell 1994;77:239-248.
32. Tumas-Brundage K, Manser T. The transcriptional promoter regulates hypermutation of the antibody heavy chain locus. J Exp Med 1997;185:239-250.
33. Sohn J, Gerstein RM, Hsieh CL, Lemer M, Selsing E. Somatic hypermutation of an immunoglobulin mu heavy chain transgene. J Exp Med 1993;177:493-504.
34. Giusti AM, Manser T. Hypermutation is observed only in antibody H chain V region transgenes that have recombined with endogenous immunoglobulin H DNA: implications for the location of cis-acting elements required for somatic mutation. J Exp Med 1993;177:797-809.
35. Lonberg N, Huszar D. Human antibodies from transgenic mice. Int Rev Immunol 1995;13:65-93.
36. Mendez MJ, et al. Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response. Nat Genet 1997;15:146-156.
37. Ernst P, Smale ST. Combinatorial regulation of transcription. General aspects of transcriptional control. Immunity 1995;2:311-319.
38. Willerford DM, Swat W, Alt FW. Developmental regulation of V(D)J recombination and lymphocyte differentiation. Curr Opin Genet Dev 1996;6:603-609.
39. Gellert M. Recent advances in understanding V(D)J recombination. Adv Immunol 1997;64:39-64.
40. Kobrin BJ, Casadevall A, Pirofski L-A, Schiff C, Scharff MD. The somatic instability of immunoglobulin genes in cultured cells. In: Steele EJ, ed. Somatic hypermutation in V regions. Boca Raton (FL): CRC Press;1990. p. 11-28.
41. Coffino P, Scharff MD. Rate of somatic mutation in immunoglobulin production by mouse myeloma cells. Proc Natl Acad Sci USA 1971;68:219-223.
42. Adetugbo K, Milstein C, Secher DS. Molecular analysis of spontaneous somatic mutants. Nature 1977;265:299-304.
43. Margulies DH, Kuehl WM, Scharff MD. Somatic cell hybridization of mouse myeloma cells. Cell 1976;8:405-415.
44. Wabl M, Jack HM, Meyer J, Beck-Engeser G. von Borstel RC, Steinberg CM. Measurements of mutation rates in B lymphocytes. Immunol Rev 1987;96:91-107.
45. Green NS, Rabinowitz JL, Zhu M, Kobrin BJ, Scharff MD. Immunoglobulin variable region hypermutation in hybrids derived from a pre-B- and a myeloma cell line. Proc Natl Acad Sci USA 1995;92:6304-6308.
46. Bachl J, Wabl M. An immunoglobulin mutator that targets G.C base pairs. Proc Natl Acad Sci USA 1996;93:851-855.
47. Cook WD, Scharff MD. Antigen-binding mutants of mouse myeloma cells. Proc Natl Acad Sci USA 1977;74:5687-5691.
48. Shin SU, DePinho R, Zack DJ, Rudikoff S, Scharff MD. Instability of immunoglobulin genes in S107 cell line. Somat Cell Mol Genet 1991;17:259-276.
49. Zhu M, Rabinowitz JL, Green NS, Kobrin BJ, Scharff MD. A well-differentiated B-cell line is permissive for somatic mutation of a transfected immunoglobulin heavy-chain gene. Proc Natl Acad Sci USA 1995;92:2810-2814.
50. Kallberg E, Jainandunsing S, Gray D, Leanderson T. Somatic mutation of immunoglobulin V genes in vitro. Science 1996;271:1285-1289.
51. Razanajaona D, et al. In vitro triggering of somatic mutation in naive B cells. J Immunol 1997;159:3347-3353.
52. Denépoux S, et al. Induction of somatic mutation in a human B cell line in vitro. Immunity 1997;6:35-46.
53. Luria SE, Delbruck M. Mutation of bacteria from virus sensitivity to virus resistance. Genetics 1943;28:491-511.
54. Lea DE, Coulson CA. The distribution of the number of mutations in bacterial population. J Genet 1949;119:264-267.
55. Zhu M, Green NS, Rabinowitz JL, Scharff MD. Differential V region mutation of two transfected Ig genes and their interaction in cultured B cell lines. EMBO J 1996;15:2738-2747.
56. Lin M, Chang CJ, Green NS. A new method for estimating high mutation rates in cultured cells. Mutat Res 1996;351:105-116.
57. Bachl J, Wabl M. Enhancers of hypermutation. Immunogenetics 1996;45:59-64.
58. Lin MM, Zhu M, Scharff MD. Sequence dependent hypermutation of the immunoglobulin heavy chain in cultured B cells. Proc Natl Acad Sci USA 1997;94:5284-5289.
59. Hansberg D, Briles DE, Davie JM. Analysis of the diversity of murine antibodies to dextran B1355. I. Generation of a large pauci-clonal response to a bacterial pathogen. J Immunol 1976;117:569-575.
60. Chui YL, Lozano F, Jarvis JM, Pannell R, Milstein C. A reporter gene to analyse the hypermutation of immunoglobulin genes. J Mol Biol 1995;249:555-563.
61. Azuma T, Motoyama N, Fields LE, Loh DY. Mutations of the chloramphenicol acetyl transferase transgene driven by the immunoglobulin promoter and intron enhancer. Int Immunol 1993;5:121-130.
62. Umar A, Schweitzer PA, Levy NS, Gearhart JD, Gearhart PJ. Mutation in a reporter gene depends on proximity to and transcription of immunoglobulin variable transgenes. Proc Natl Acad Sci USA 1991;88:4902-4906.
63. Goyenechea B, Milstein, C. Modifying the sequence of an immunoglobulin V gene alters the resulting pattern of hypermutation. Proc Natl Acad Sci USA 1996;93:13979-13984.
64. Green NS, Verdugo G, Getman ME, Scharff MD. Immunoglobulin variable region hypermutation in B cell hybrids. Mol Immunol 1997;34:1095-1103.
65. Maizels N, Lau JC, Blier PR, Bothwell A. The T-cell independent antigen, NP-ficoll, primes for a high affinity IgM anti-NP response. Mol Immunol 1988;25:1277-1282.
66. Jacob J, Przylepa J, Miller C, Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells. J Exp Med 1993;178:1293-1307.
67. Migliazza A, et al. Frequent somatic hypermutation of the 5′ non-coding region of the BCL-6 gene in B cell lymphomas. Proc Nat Acad Sci USA 1996;92:12520-12524.
68. Kim S, Davis M, Sinn E, Patten P, Hood L. Antibody diversity: somatic hypermutation of rearranged VH genes. Cell 1981;27:573-581.
69. Gearhart PJ. Generation of immunoglobulin variable gene diversity. Immunol Today 1982;3:107-112.
70. Chien NC, Pollock RR, Desaymard C, Scharff MD. Point mutations cause the somatic diversification of IgM and IgG2a antiphosphorylcholine antibodies. J Exp Med 1988;167:954-973.
71. Peters A, Storb U. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 1996;4:57-65.
72. Jack H-M, Wabl M. High rates of deletions in the constant region segment of the immunoglobulin m gene. Proc Natl Acad Sci USA 1987;84:4934-4938.
73. Levy R, et al. Somatic mutation in human B-cell tumors. Immunol Rev 1987;96:43-58.
74. Rickert R, Clarke S. Low frequencies of somatic mutation in two expressed V kappa genes: unequal distribution of mutation in 5′ and 3′ flanking regions. Int Immunol 1993;5:255-263.
75. Shatz DG, Oettinger MA, Baltimore D. The V(D)J recombination activating gene, Rag-1. Cell 1989;59:1035-1048.